Status:
ACTIVE_NOT_RECRUITING
Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.
Lead Sponsor:
Centre Georges Francois Leclerc
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
This study will quantify the muscle function after breast reconstruction using a minimally invasive latissimus dorsi flap. The proposed measures (clinical, isokinetic, electrophysiology, function and...
Eligibility Criteria
Inclusion
- Patient managed for unilateral MR (immediate or secondary) by MSLD after therapeutic mastectomy.
- Breast assessment (Mammography + ultrasound +/- breast MRI) normal dating less than 6 months
- Age between 18 and 80 years old
- Signature of free and informed consent
Exclusion
- Patient with metastasis or disease progression
- Patient whose general condition does not allow her to answer a questionnaire or perform physical and functional measurements (neurocognitive disorders and/or neuro-orthopedic disorders)
- Patient with a poor understanding of the French language
- Patient having presented a failure of a first breast reconstruction (failure of DIEP, prosthesis removal)
- Patient not eligible for MR secondary to cancer (prophylactic mastectomy) or for which the flap was intended to cover loss of substance and not reconstruction
- Patient with a history of contralateral MR (all techniques combined)
- Patient with a history of contralateral breast cancer
- Patient does not have internet access to be able to connect to the "Exolis" software
Key Trial Info
Start Date :
November 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 4 2026
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05278741
Start Date
November 25 2022
End Date
December 4 2026
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Georges-François Leclerc
Dijon, Côte d'Or, France, 21000